Essex Woodlands Health Ventures VIII L.L.C. 13D and 13G filings for Revance Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-10 06:01 am Sale | 2021-01-20 | 13G | Revance Therapeutics, Inc. RVNC | Essex Woodlands Health Ventures VIII L.L.C. | 457,085 0.007% | -2,884,962 (-86.32%) | Filing |